Seek Returns

ABBV vs. NVDA: AbbVie vs. NVIDIA Stock Comparison

How do AbbVie (ABBV) and NVIDIA (NVDA) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas NVIDIA (NVDA) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and NVIDIA (NVDA)
Profile ItemABBVNVDA
NameAbbVie Inc.NVIDIA Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareInformation Technology
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesSemiconductors & Semiconductor Equipment
GICS IndustryBiotechnologySemiconductors & Semiconductor Equipment
GICS Sub-IndustryBiotechnologySemiconductors
Market Capitalization514.92 billion USD4,506.80 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateJanuary 2, 2013January 22, 1999
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ABBV
NVDA
GSPC
Loading price history…
AbbVie (ABBV) vs. NVIDIA (NVDA), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and NVIDIA (NVDA). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and NVIDIA (NVDA). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
Total Return (1Y)37.33%-5.54%
Total Return (3Y, Annualized)32.74%55.88%
Total Return (5Y, Annualized)24.73%42.17%

Risk Profile

Drawdown History

ABBV
NVDA
GSPC
Loading price history…
AbbVie (ABBV) vs. NVIDIA (NVDA), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and NVIDIA (NVDA). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

NVIDIA (NVDA) has a highly aggressive beta of 2.28, indicating much higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk profile metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
Volatility (1Y, Annualized)25.65%38.31%
Beta (5Y)0.212.28
Max Drawdown (5Y)-21.92%-66.34%
Avg. Volume (3M)4.76M120.20M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ABBV and NVDA are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
Sharpe Ratio (1Y)1.29-0.26
Sortino Ratio (1Y)2.02-0.36

Profitability

ROE (TTM)

Capital efficiency shows on one side only: NVIDIA (NVDA) earns 117.21% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--

NVDA

Semiconductors & Semiconductor Equipment industry group

117.21%

NVDA
117.21%
Max
52.82%
Q3
22.26%
Median
10.58%
Q1
1.29%
Min
-16.89%
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): ABBV does not report ROE, so it has no value marker; NVDA is benchmarked against the Semiconductors & Semiconductor Equipment industry group.

Net Margin (TTM)

For every dollar of sales, both AbbVie (ABBV) at 15.67% and NVIDIA (NVDA) at 63.66% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

NVDA

Semiconductors & Semiconductor Equipment industry group

63.66%

Max
63.80%
NVDA
63.66%
Q3
28.36%
Median
11.44%
Q1
0.90%
Min
-37.77%
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Operating Margin (TTM)

NVIDIA (NVDA) at 66.24% shows unusually strong operating efficiency — above its industry’s operating margin range — and AbbVie (ABBV) at 39.59% also operates in the top quartile.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

NVDA

Semiconductors & Semiconductor Equipment industry group

66.24%

NVDA
66.24%
Max
58.66%
Q3
30.23%
Median
15.91%
Q1
7.54%
Min
-25.74%
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
ROE (TTM)--117.21%
ROA (TTM)10.74%53.57%
Net Margin (TTM)15.67%63.66%
Operating Margin (TTM)39.59%66.24%
Gross Margin (TTM)73.72%74.67%

Growth

Revenue Growth

NVIDIA (NVDA) at 65.47% clears its industry range for revenue growth, far stronger top-line momentum than AbbVie (ABBV) at 8.57%, which is closer to a typical peer reading.

Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their Revenue Growth across different time periods.

EPS Growth

NVIDIA (NVDA) at 66.67% sits in the top EPS growth quartile, while AbbVie (ABBV) at -0.84% is closer to the peer norm — faster per-share earnings growth for NVDA.

Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
Revenue Growth (YoY)8.57%65.47%
Revenue Growth (3Y CAGR)1.75%100.05%
EPS Growth (YoY)-0.84%66.67%
EPS Growth (3Y CAGR)-29.03%204.24%

Financial Strength

Current Ratio (MRQ)

NVIDIA (NVDA) at 4.59 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10

NVDA

Semiconductors & Semiconductor Equipment industry group

4.59

Max
10.33
Q3
5.62
NVDA
4.59
Median
3.33
Q1
2.35
Min
1.03
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: NVIDIA (NVDA) carries debt-to-equity ratio of 0.17 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--

NVDA

Semiconductors & Semiconductor Equipment industry group

0.17

Max
1.46
Q3
0.65
Median
0.27
NVDA
0.17
Q1
0.04
Min
0.00
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): ABBV does not report debt-to-equity ratio, so it has no value marker; NVDA is benchmarked against the Semiconductors & Semiconductor Equipment industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
Current Ratio (MRQ)0.874.59
Debt / Equity (MRQ)--0.17
Net Debt / EBITDA2.21-0.12

Dividends

Dividend Yield (TTM)

NVIDIA (NVDA) at 0.15% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

NVDA

Semiconductors & Semiconductor Equipment industry group

0.15%

Max
1.37%
Q3
0.65%
NVDA
0.15%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile NVIDIA (NVDA) reports 3.54%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

NVDA

Semiconductors & Semiconductor Equipment industry group

3.54%

Max
49.64%
Q3
21.71%
NVDA
3.54%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
Dividend Yield (TTM)2.40%0.15%
Dividend Payout Ratio (TTM)117.35%3.54%

Valuation

P/E Ratio (TTM)

NVIDIA (NVDA) at 23.60 sits in the cheaper P/E ratio quartile, while AbbVie (ABBV) at 50.05 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

NVDA

Semiconductors & Semiconductor Equipment industry group

23.60

Max
110.34
Q3
66.81
Median
37.02
Q1
23.96
NVDA
23.60
Min
8.12
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while NVIDIA (NVDA) at 14.88 sits in the pricier quartile — NVDA costs more per dollar of sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01

NVDA

Semiconductors & Semiconductor Equipment industry group

14.88

Max
21.42
NVDA
14.88
Q3
12.27
Median
5.76
Q1
2.73
Min
0.00
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile NVIDIA (NVDA) reports 19.68, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34

NVDA

Semiconductors & Semiconductor Equipment industry group

19.68

NVDA
19.68
Max
14.06
Q3
7.44
Median
4.29
Q1
2.30
Min
0.20
Loading chart…
AbbVie (ABBV) vs. NVIDIA (NVDA): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and NVIDIA (NVDA)
MetricABBVNVDA
P/E Ratio (TTM)50.0523.60
P/S Ratio (TTM)7.8014.88
P/B Ratio (MRQ)-112.3419.68
Free Cash Flow Yield (TTM)3.44%0.93%